Neuropathy Nugget #3: Is vitamin B1 (thiamine) deficiency a cause of peripheral neuropathy in diabetics?

Which of the following is true?

A. Vitamin B1 deficiency is a common cause of peripheral neuropathy in diabetics.
B. Vitamin B1 deficiency can cause peripheral neuropathy but it is very uncommon in diabetics.
C. Vitamin B1 deficiency does not cause peripheral neuropathy.

Many studies have shown that diabetics are very often vitamin B1 (thiamine) deficient. This is probably true for prediabetics, although this relationship has not been studied.  Vitamin B1 deficiency is a well-known cause of peripheral neuropathy.  Reversing vitamin B1 deficiency with benfotiamine, the high potency form of vitamin B1, has been shown in many studies to dramatically improve the symptoms of peripheral neuropathy in diabetics.

Benfotiamine is a high potency form of vitamin B1.  It currently being used successfully by thousands of physicians for their diabetic and prediabetic patients with burning, tingling, numbness and shooting pains in their feet and legs.  Benfotiamine, the key ingredient in NeuRemedy®,is safe, well-studied and, when used properly, helps to reduce burning, tingling, numbness and shooting pains in the feet and legs within the first 30 days of use.

The correct answer is:

A. Vitamin B1 deficiency is a common cause of peripheral neuropathy.

Vitamin B1deficiency is often a factor in the peripheral neuropathy suffered by diabetics and is best reversed by the proper use of benfotiamine, a high potency form of vitamin B1.


Dr. Mann, Bio picture, Founder of Realm Labs, makers of NeuRemedy

This Neuropathy Nugget was authored by

Dr. Richard Mann, CEO, and Founder of Realm Labs, makers of NeuRemedy®
📱561-549-9099 |  🖥️ www.neuremedy.com

NeuRemedy® improves the function of the nerves in the feet and legs.* NeuRemedy® is licensed by Health Canada to support the healthy function of nerves in individuals with polyneuropathy.*

Be sure to check out Neuropathy Nugget #4: Does the use of metformin impact thiamine (vitamin B1) utilization?

Leave a Reply

Your email address will not be published. Required fields are marked *